Ellagic acid supplementation effect in patients with Major Depressive
Phase 3
Recruiting
- Conditions
- Major depressive episode.Major depressive disorder, single episode
- Registration Number
- IRCT20141025019669N15
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Men and women with Major Depressive
Willingness to work
Age 18- 55
Non-modification of treatment and medications for at least the past 2 months
Exclusion Criteria
Pregnancy and breastfeeding
Patients with severe renal and hepatic dysfunction
Alcohol consumption
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of depression. Timepoint: Before the intervention and after the intervention. Method of measurement: Hamilton Rating Scale.
- Secondary Outcome Measures
Name Time Method Total antioxidant capacity. Timepoint: Before the intervention and after the intervention. Method of measurement: Eliza.;Malondialdehyde. Timepoint: Before the intervention and after the intervention. Method of measurement: Eliza.